Literature DB >> 34387294

[3 + 2]-Annulation of pyridinium ylides with 1-chloro-2-nitrostyrenes unveils a tubulin polymerization inhibitor.

Alexander V Aksenov1, Nikolai A Arutiunov, Nikita K Kirilov, Dmitrii A Aksenov, Igor Yu Grishin, Nicolai A Aksenov, Huifen Wang, Liqin Du, Tania Betancourt, Stephen C Pelly, Alexander Kornienko, Michael Rubin.   

Abstract

Indolizines and pyrazolo[1,5-a]pyridines were prepared via [3 + 2]-cycloaddition of pyridinium ylides to 1-chloro-2-nitrostyrenes. The synthesized molecules were evaluated for antiproliferative activities against a BE(2)-C neuroblastoma cell line with several compounds decreasing the viability of cancer cells. Indolizine 9db showed higher potency than that of all-trans-retinoic acid, an approved cancer drug. Mechanistically, it was found to inhibit tubulin polymerization and it is thus proposed that the discovered chemistry can be exploited for the development of novel microtubule-targeting anticancer agents.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34387294      PMCID: PMC8439629          DOI: 10.1039/d1ob01141c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.890


  35 in total

Review 1.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

Review 2.  Discovery, understanding, and bioapplication of organic fluorophore: a case study with an indolizine-based novel fluorophore, Seoul-Fluor.

Authors:  Eunha Kim; Youngjun Lee; Sanghee Lee; Seung Bum Park
Journal:  Acc Chem Res       Date:  2015-02-19       Impact factor: 22.384

3.  Novel pyrazolo[1,5-a]pyridines as orally active EP1 receptor antagonists: Synthesis, structure-activity relationship studies, and biological evaluation.

Authors:  Kentaro Umei; Yosuke Nishigaya; Atsushi Kondo; Kazuya Tatani; Nobuyuki Tanaka; Yasushi Kohno; Shigeki Seto
Journal:  Bioorg Med Chem       Date:  2017-03-14       Impact factor: 3.641

Review 4.  New drug binding sites in Ca2+ channels.

Authors:  M Spedding; B Kenny; P Chatelain
Journal:  Trends Pharmacol Sci       Date:  1995-04       Impact factor: 14.819

Review 5.  Topoisomerase I inhibitors: camptothecins and beyond.

Authors:  Yves Pommier
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

6.  Synthesis of Spiro[indole-3,5'-isoxazoles] with Anticancer Activity via a Formal [4 + 1]-Spirocyclization of Nitroalkenes to Indoles.

Authors:  Alexander V Aksenov; Dmitrii A Aksenov; Nikolai A Arutiunov; Nicolai A Aksenov; Elena V Aleksandrova; Zhenze Zhao; Liqin Du; Alexander Kornienko; Michael Rubin
Journal:  J Org Chem       Date:  2019-05-22       Impact factor: 4.354

Review 7.  Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.

Authors:  Panayotis Pantazis; Zhiyong Han; Kannan Balan; Yongbao Wang; James H Wyche
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

8.  Preparation of Stereodefined 2-(3-Oxoindolin-2-yl)-2-Arylacetonitriles via One-Pot Reaction of Indoles with Nitroalkenes.

Authors:  Alexander V Aksenov; Dmitrii A Aksenov; Nicolai A Aksenov; Elena V Aleksandrova; Michael Rubin
Journal:  J Org Chem       Date:  2019-09-18       Impact factor: 4.354

Review 9.  Indolizidine and quinolizidine alkaloids.

Authors:  Joseph P Michael
Journal:  Nat Prod Rep       Date:  2007-12-13       Impact factor: 13.423

Review 10.  Electrophilically Activated Nitroalkanes in Reactions With Carbon Based Nucleophiles.

Authors:  Nicolai A Aksenov; Alexander V Aksenov; Sergei N Ovcharov; Dmitrii A Aksenov; Michael Rubin
Journal:  Front Chem       Date:  2020-02-11       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.